These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21262447)

  • 21. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
    Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
    Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. YC-1 reduces placental sFlt-1 and soluble endoglin production and decreases endothelial dysfunction: A possible therapeutic for preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Tuohey L; Kaitu'u-Lino TJ
    Mol Cell Endocrinol; 2015 Sep; 413():202-8. PubMed ID: 26159901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.
    Hannan NJ; Brownfoot FC; Cannon P; Deo M; Beard S; Nguyen TV; Palmer KR; Tong S; Kaitu'u-Lino TJ
    Sci Rep; 2017 May; 7(1):1819. PubMed ID: 28500309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Soluble endoglin (sEng) joins the soluble fms-like tyrosine kinase (sFlt) receptor as a pre-eclampsia molecule.
    Luft FC
    Nephrol Dial Transplant; 2006 Nov; 21(11):3052-4. PubMed ID: 16870672
    [No Abstract]   [Full Text] [Related]  

  • 26. Uteroplacental arterio-venous difference in soluble VEGFR-1 (sFlt-1), but not in soluble endoglin concentrations in preeclampsia.
    Paasche Roland MC; Lorentzen B; Godang K; Henriksen T
    Placenta; 2012 Mar; 33(3):224-6. PubMed ID: 22264588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells.
    Brownfoot FC; Hannan N; Onda K; Tong S; Kaitu'u-Lino T
    Placenta; 2014 Sep; 35(9):724-31. PubMed ID: 25043692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome.
    Hastie R; Ye L; Hannan NJ; Brownfoot FC; Cannon P; Nguyen V; Tong S; Kaitu'u-Lino TJ
    Pregnancy Hypertens; 2018 Oct; 14():125-130. PubMed ID: 30527099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New insights into the pathogenesis of pre-eclampsia: the role of angiogenesis-inhibiting factors].
    Verdonk K; Visser W; Steegers EA; Kappers M; Danser AH; van den Meiracker AH
    Ned Tijdschr Geneeskd; 2011; 155():A2946. PubMed ID: 21486506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased plasma soluble fms-like tyrosine kinase 1 and endoglin levels in pregnancies complicated with preeclampsia.
    Chedraui P; Lockwood CJ; Schatz F; Buchwalder LF; Schwager G; Guerrero C; Escobar GS; Hidalgo L
    J Matern Fetal Neonatal Med; 2009 Jul; 22(7):565-70. PubMed ID: 19350449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of sildenafil citrate on circulating levels of sFlt-1 in preeclampsia.
    Brownfoot FC; Tong S; Hannan NJ; Cannon P; Nguyen V; Kaitu'u-Lino TJ
    Pregnancy Hypertens; 2018 Jul; 13():1-6. PubMed ID: 30177033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glyceryl trinitrate inhibits hypoxia-induced release of soluble fms-like tyrosine kinase-1 and endoglin from placental tissues.
    Barsoum IB; Renaud SJ; Graham CH
    Am J Pathol; 2011 Jun; 178(6):2888-96. PubMed ID: 21641407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble endoglin contributes to the pathogenesis of preeclampsia.
    Venkatesha S; Toporsian M; Lam C; Hanai J; Mammoto T; Kim YM; Bdolah Y; Lim KH; Yuan HT; Libermann TA; Stillman IE; Roberts D; D'Amore PA; Epstein FH; Sellke FW; Romero R; Sukhatme VP; Letarte M; Karumanchi SA
    Nat Med; 2006 Jun; 12(6):642-9. PubMed ID: 16751767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia.
    Rana S; Karumanchi SA; Levine RJ; Venkatesha S; Rauh-Hain JA; Tamez H; Thadhani R
    Hypertension; 2007 Jul; 50(1):137-42. PubMed ID: 17515455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low Soluble Fms-Like Tyrosine Kinase-1, Endoglin, and Endothelin-1 Levels in Women With Confirmed or Suspected Preeclampsia Using Proton Pump Inhibitors.
    Saleh L; Samantar R; Garrelds IM; van den Meiracker AH; Visser W; Danser AHJ
    Hypertension; 2017 Sep; 70(3):594-600. PubMed ID: 28716993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis.
    Tal R
    Biol Reprod; 2012 Jun; 87(6):134. PubMed ID: 23034156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A wash step at collection of placental biopsies from preeclamptic pregnancies does not adversely affect levels of sFlt-1 or endoglin.
    Kaitu'u-Lino TJ; Hannan NJ; De Silva M; Binder N; Tuohey L; Cannon P; Tong S
    Pregnancy Hypertens; 2015 Oct; 5(4):294-7. PubMed ID: 26597743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Melatonin enhances antioxidant molecules in the placenta, reduces secretion of soluble fms-like tyrosine kinase 1 (sFLT) from primary trophoblast but does not rescue endothelial dysfunction: An evaluation of its potential to treat preeclampsia.
    Hannan NJ; Binder NK; Beard S; Nguyen TV; Kaitu'u-Lino TJ; Tong S
    PLoS One; 2018; 13(4):e0187082. PubMed ID: 29641523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.